Subchronic and Developmental Toxicity of Aromatic Extracts

International Journal of Toxicology

Volumn 33, Issue , 2014, Pages 136S-155S

  Dalbey, Walden E ^a   McKee, Richard H ^b   Goyak, Katy Olsavsky ^b   Charlap, Jeffrey H ^c   Parker, Craig ^d   White, Russell ^e  

^a DalbeyTox LLC   (United States)

^b EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

^c WIL RESEARCH LABORATORIES   (United States)

^d Petroleum HPV Testing Group   (United States)

^e AMERICAN PETROLEUM INSTITUTE   (United States)

Author keywords

aromatic extract; dermal; developmental; micronucleus; petroleum; rat; subchronic; toxicity

Indexed keywords

CARCINOGEN; PETROLEUM; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL; AROMATIC EXTRACT; ARTICLE; BIOASSAY; DERMAL; DEVELOPMENTAL; DOSE RESPONSE; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; FEMALE; FETUS DEVELOPMENT; MALE; METABOLISM; MICRONUCLEUS; MICRONUCLEUS TEST; RAT; REPRODUCTION; SKIN; SPRAGUE DAWLEY RAT; SUBCHRONIC; TOXICITY; TOXICITY TESTING;

AROMATIC EXTRACT; DERMAL; DEVELOPMENTAL; MICRONUCLEUS; PETROLEUM; RAT; SUBCHRONIC; TOXICITY;

ANIMALS; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDPOINT DETERMINATION; FEMALE; FETAL DEVELOPMENT; MALE; MICRONUCLEUS TESTS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PETROLEUM; POLYCYCLIC HYDROCARBONS, AROMATIC; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCTION; SKIN; TOXICITY TESTS, SUBCHRONIC;

EID: 84907846031     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581813517724     Document Type: Article

References (44)

1. US EPA. Data collection and development on high production volume (HPV) chemicals. Fed Reg. 2000; 65(248):81686.
2. PHPVTG (Petroleum HPV Testing Group). High Production Volume (HPV) Chemical Challenge Program. Aromatic Extracts Category Assessment Document. Submitted to the U.S. Environmental Protection Agency; 2012. http://www.petroleumhpv.org/pages/aromaticextracts.html. Accessed May 21, 2012.
3. Briggs T, Mackerer CR. The Chemistry and Toxicology of Petroleum Hydrocarbons. Washington, DC: AIHCE Professional Development Course; 1996.
4. Roy TA, Blackburn GR, Mackerer CR. Evaluation of physicochemical factors affecting dermal penetration and carcinogenic potency of mineral oils containing polycyclic aromatic compounds. Polycycl Aromat Comp. 1996; 10 (1/4): 333–342.
5. Roy T, Johnson S, Blackburn G, Mackerer C. Correlation of mutagenic and dermal carcinogenic activities of mineral oils with polycyclic aromatic content. Fundam Appl Toxicol. 1988; 10(3):466–476.
6. Simpson B, Dalbey W, Fetzer J, et al. The relationship between the aromatic ring class content and repeat-dose and developmental toxicities of petroleum substances boiling above approximately 300°F. Toxicologist. 2008; 102(1):52.
7. Cruzan G, Low LK, Cox GE, et al. Systemic toxicity from subchronic dermal exposure, chemical characterization and dermal penetration of catalytically cracked clarified slurry oil. Toxicol Ind Health. 1986; 2(4):4294–44.
8. Blackburn G, Deitch R, Schreiner C, Mackerer C. Predicting tumorigenicity of petroleum distillation fractions using a modified Salmonella mutagenicity assay. Cell Biol Toxicol. 1986; 2(1):63–84.
9. McKee RH, Lewis SC. Evaluation of the dermal carcinogenic potential of liquids produced from the Cold Lake heavy oil deposits of Northeast Alberta. Can J Physiol Pharmacol. 1987; 65(8):1793–1797.
10. Blackburn GR, Roy TA, Bleicher WT Jr, Reddy M, Mackerer CR. Comparison of biological and chemical predictors of dermal carcinogenicity of petroleum oils. Polycycl Aromat Comp. 1996; 11(1-4):201–210.
11. CONCAWE (Conservation of Clean Air and Water in Europe). Use of the Modified AMES Test as an Indicator of the Carcinogenicity of Residual Aromatic Extracts. CONCAWE Report No. 12/12. Brussels: CONCAWE; 2012.
12. CONCAWE (Conservation of Clean Air and Water in Europe). Aromatic Extracts. Product Dossier No. 92/101. Brussels: CONCAWE; 1992.
13. Kane ML, Ladov EN, Holdsworth CE, Weaver NK. Toxicological characteristics of refinery streams used to manufacture lubricating oils. Am J Ind Med. 1984; 5(3):183–200.
14. Doak SMA, Hend RW, Vanderweil A, Hunt PF. Carcinogenic potential of hydrotreated aromatic extracts. Brit J Ind. 1985; 42(6):380–388.
15. Gradiski D, Vinot D, Zissu JC, Limasset JC, Lafontaine M. The carcinogenic effects of a series of petroleum-derived oils on the skin of mice. Environ Res. 1983; 32(2):258–268.
16. Lewis SC, King RW, Cragg ST, Hillman DW. Skin carcinogenic potential of petroleum hydrocarbons. II. Crude oil, distillate fractions and chemical class subfractions. In: MacFarland HN, Holdsworth CE, MacGregor JA, Call RW, Kane ML.,eds. Advances in Modern Environmental Toxicology. Vol I: Applied Toxicology of Petroleum Hydrocarbons. Princeton, NJ: Princeton Scientific; 1984: 139–150.
17. Feuston MH, Low LK, Hamilton CE, Mackerer CR. Correlation of systemic and developmental toxicities with chemical component classes of refinery streams. Fundam Appl Toxicol. 1994; 22(4):622–630.
18. Feuston M, Hamilton C, Mackerer C. Systemic and developmental toxicity of dermally applied distillate aromatic extract in rats. Fundam Appl Toxicol. 1996; 30(2):276–284.
19. US EPA. Hazard Characterization Document. Screening-Level Hazard Characterization of High Production Volume Chemicals. Chemical Category Name: Aromatic Extracts. TSCATS (OTS0540342); 2012.
20. Murray FJ, Roth RN, Nicolich MJ, Gray TM, Simpson BJ. The relationship between developmental toxicity and aromatic ring class content of high boiling petroleum substances. Regul Toxicol Pharmacol. 2013; 67(2 suppl):S46–S59.
21. Nicolich M, Simpson B, Murray J, Roth R, Gray T. The development of statistical models to determine the relationship between the aromatic ring class content and repeat-dose and developmental toxicities of high boiling petroleum substances. Regul Toxicol Pharmacol. 2013; 67(2 suppl):S10–S29.
22. Roth R, Simpson B, Nicolich M, Murray R, Gray T. The relationship between repeat dose toxicity and aromatic ring class content of high boiling petroleum substances. Regul Toxicol Pharmacol. 2013; 67(2 suppl):S30–S45.
23. US EPA. Office of Pollution Prevention and Toxics. Section 5.7 of Guidance for Meeting the SIDS Requirements: Chemical Right-to-Know Initiative; 2010. http://www.epa.gov/opptintr/chemrtk/sidsappb.htm. Accessed November 3, 1998.
24. Blazak WF, Ernst TL, Stewart BE. Potential indicators of reproductive toxicity: testicular sperm production and epididymal number, transit time, and motility in Fischer 344 rats. Fundam Appl Toxicol. 1985; 5(6 pt 1):1097–1103.
25. Wyrobek AJ, Gordon LA, Burkhart JG, et al. An evaluation of the mouse sperm morphology and other sperm tests in nonhuman mammals. a report of the U.S. environmental protection agency gene-tox program. Mutat Res. 1983; 115(1):1–72.
26. Salewski E. Farbemethodezummakroskopischenmachweis von implantationsstellen am uterus der ratte [Staining method for a macroscopic test for implantation sites in the uterus of the rat]. Arch Pathol Exp Pharmacol. 1964; 247: 367.
27. Stuckhardt J, Poppe S. Fresh visceral examination of rat and rabbit fetuses used in teratogenicity testing. Teratog Carcinog Mutagen. 1984; 4(2):181–188.
28. Woo D, Hoar R. Apparent hydronephrosis as a normal aspect of renal development in late gestation of rats: the effect of methyl salicylate. Teratology. 1972; 6(2):191–196.
29. Wilson J. Embryological considerations in teratology. In: Wilson J, Warkany J, eds. Teratology: Principles and Techniques. Chicago, IL: The University of Chicago Press; 1965: 251–277.
30. Wilson JG. Atlas of free hand (razor blade) sections of the normal 20-day rat fetus. In: Lee DHK, Hewson EW, Okum D, eds. Environmental and Birth Defects. New York, NY: Academic Press; 1973: 227–232.
31. Inouye M. Differential staining of cartilage and bone in fetal mouse skeleton by Alcian blue and Alizarin red S. Congenital Anomalies. 1976; 16(3):171–173.
32. Kimmel CA, Trammel C. A rapid procedure for routine double staining of cartilage and bone in fetal and adult animals. Stain Technol. 1981; 56(5):271–273.
33. Roy T, Johnson S, Blackburn G, Deitch R, Schreiner C, Mackerer C. Estimation of mutagenic and dermal carcinogenic activities of petroleum fractions based on polynuclear aromatic hydrocarbon content. In: Cooke M, Dennis A, eds. Polynuclear Aromatic Hydrocarbons: A Decade of Progress. 10th International Symposium. Columbus, OH: Battelle Press; 1985; 809–824.
34. Gray T, Simpson B, Nicolich M, et al. Assessing the mammalian toxicity of high boiling petroleum substances under the rubric of the HPV program. Regul Toxicol Pharmacol. 2013; 67(2 suppl):S4–S9.
35. Crump K. A new method for determining allowable daily intakes. Fundam Appl Toxicol. 1984; 4(5):854–871.
36. Potter D, Booth ED, Brandt HCA, et al. Studies on the dermal and systemic bioavailability of polycyclic aromatic compounds in high viscosity oil products. Arch Toxicol. 1999; 73(3):129–140.
37. McKee RH, Schreiner C, Nicolich MJ, Gray T. Genetic toxicity of high boiling petroleum substances. Regul Toxicol Pharmacol. 2013; 67(2 suppl):S75–S85.
38. Przygoda RT, McKee RH, Amoruso MA, Freeman JJ. Assessment of the utility of the micronucleus test for petroleum-derived materials. Mutat Res. 1999; 438(2):145–153.
39. Feuston MH, Mackerer CR. Developmental toxicity of clarified slurry oil, syntower bottoms, and distillate aromatic extract administered as a single oral dose to pregnant rats. J Toxicol Environ Health. 1996; 49(1):45–66.
40. IP 346/80. Polycyclic aromatics in petroleum fractions by dimethyl sulfoxide refractive index method. In: Methods for Analysis and Testing. Vol. 2. New York: Wiley; 1985: 346.1–346.6.
41. Murray FJ, Gray TM, Roberts LG, Roth RN, Nicolich MJ, Simpson BJ. Evaluating the male and female reproductive toxicity of high-boiling petroleum substances. Regul Toxicol Pharmacol. 2013; 67(2 suppl):S60–S74.
42. Hoberman A, Christian M, Roth R, Lovre S, Koschier F. Reproductive toxicity study of clarified slurry oil in the rat. J Am Coll Toxicol. 1995; 14(2):119–128.
43. Feuston MH, Hamilton CE, Mackerer CR. Systemic and developmental toxicity of dermally applied syntower bottoms in rats. Fundam Appl Toxicol. 1997; 35(2):166–176.
44. Hoberman A, Christian M, Lovre S, Roth R, Koschier F. Developmental toxicity study of clarified slurry oil (CSO) in the rat. Fundam Appl Toxicol. 1995; 28(1):34–40.